In the news release, New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Duloxetine, issued 11-Sep-2009 by Eli Lilly and Company over PR Newswire, the third paragraph, third sentence should read "A total of 18 patients in the study discontinued due to adverse events during the extension phase." The phrase "13 in the placebo-treated group and five in the duloxetine-treated group" at the end of that sentence should be disregarded. The complete, corrected release follows: